Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Farmers Insurance
Deloitte
Boehringer Ingelheim
Cantor Fitzgerald
Teva
Covington
Colorcon
Moodys

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087510

« Back to Dashboard

NDA 087510 describes PROCAN SR, which is a drug marketed by Parke Davis and Parkedale and is included in four NDAs. Additional details are available on the PROCAN SR profile page.

The generic ingredient in PROCAN SR is procainamide hydrochloride. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
Summary for 087510
Tradename:PROCAN SR
Applicant:Parkedale
Ingredient:procainamide hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 087510

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength750MG
Approval Date:Apr 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Julphar
Johnson and Johnson
Queensland Health
US Army
McKesson
Cantor Fitzgerald
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.